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Summary.-Adult CBA mice thymectomized, treated with antilymphocytic globulin
(ALG) and inoculated with human leprosy organisms were accidentally infected
with polyoma virus and all developed tumours. After cessation of ALG adminis-
tration, some animals were given spleen cells from syngeneic donors immunized
with polyoma virus; none developed tumours. Similar results were obtained in
mice deliberately infected with polyoma virus but not with leprosy organisms.
Passive transfer of antibody before but not after virus inoculation prevented tumour
formation in immunosuppressed recipients. Virus infection in thymectomized,
lethally irradiated and bone marrow reconstituted mice resulted in only a very low
incidence of tumours. These results emphasize the role of immunological sur-
veillance in preventing polyoma tumour formation under natural conditions.
LONG-TERM immunosuppression in-
creases the frequency of neoplasia and
reduces induction time after laboratory
infection or inoculation of polyoma or
leukaemogenic viruses into adult mice
(Law, 1966; Allison and Taylor, 1967;
Allison and Law, 1968). During an
attempt to transmit progressive human
leprosy (Mycobacterium leprae) to mice,
multiple tumours arose in all mice thy-
mectomized as adults and treated with
heterologous antilymphocytic IgG (ALG),
which impairs cell-mediated immunity.
These tumours were indistinguishable
from those induced by polyoma virus.
Virological, serological and electron mi-
croscopical studies demonstrated that
polyoma virus, possibly arising by con-
tamination of the isolation cabinet in
which the mice were kept, was responsible
for induction of at least the majority of
the tumours (Gaugas et al., 1969). Anti-
polyoma antibodies were ultimately
present in the normal control mice, so
these must have been similarly exposed to
the virus but remained tumour free. In
fact, polyoma virus is commonly present
in many laboratory and wild mouse
colonies but tumours are rarely, if ever,
seen (Rowe, Hartley and Huebner, 1961).
In contrast, inoculation of the virus into
newborn mice and certain other rodents,
carnivores and lagomorphs is followed by
the formation of a variety of lesions in
different tissues (Stewart, Eddy and
Borgese, 1958; Chesterman, 1961; Stanton
and Otsuka, 1963; Pomerance and Chester-
man, 1965; Lehman and Defendi, 1970).
Since reporting our findings, we again
attempted to propagate human leprosy
bacilli in immunosuppressed mice. The
appearance of polyoma-type tumours in
ALG-treated mice again curtailed the
study. In contrast, mice which had been
kept under similar conditions after adult
thymectomy and irradiation (900 rad)
showed only a very low incidence of
tumours. Investigations were therefore
carried out to obtain information on im-
munological protection against incidental
and deliberate infection with polyoma
virus in normal, immunosuppressed (adultIMMUNOLOGICAL CONTROL OF POLYOMA VIRUS ONCOGENESIS IN MICE
thymectomy combined with either ALG
or irradiation) and in immune reconsti-
tuted mice.
MATERIALS AND METHODS
Immunosuppression of mice.-Female vir-
gin CBA mice (inbred conventional colony)
were thymectomized surgically when 6 weeks
old. One and 14 days after thymectomy
those mice about to receive antilymphocytic
globulin (ALG) were " primed " by giving an
intraperitoneal injection of 0-1 ml of normal
rabbit globulin (NRG); this increases the
effectiveness of subsequent ALG administra-
tion, presumably because mice become
tolerant to rabbit globulin (Lance and
Dresser, 1967; Gaugas and Rees, 1968).
Alternatively, 2-3 weeks after thymectomy
the mice were exposed to 900 rad whole-body
irradiation andtheirhaemopoietic tissues were
reconstituted by transplantation of isogeneic
bone marrow cells (Gaugas et al., 1969).
Mice in another group were neonatally
thymectomized (i.e. within 36 hours ofbirth).
Completeness ofthe operations was confirmed
at autopsy.
Preparation of antilymphocytic globulin.-
Anti-mouse lymphocytic serum (ALS) was
raised in New Zealand white rabbits (2-3 kg
body weight) by injection of thymocytes
collected from 6-week-old CBA mice (Levey
and Medawar, 1966) in a suspension freed of
contaminating erythrocytes (Boyle, 1968);
after complement inactivation (heating at 56°
for 30 min) erythrocytotoxic antibody was
absorbed by addition of isologous erythro-
cytes (approximately 5% packed cells added
for 30 min at 370). The globulin fraction
(ALG) was prepared by precipitation with
ammonium sulphate solution which was later
removed by dialysis (Stelos, 1967). Immuno-
suppressive potency of the ALG was demon-
strated using the skin allograft reaction
across an H-2 locus barrier in a standard
procedure (Levey and Medawar, 1966).
Mice were injected subcutaneously into the
interscapular region once weekly with ALG
equivalent to 0-4 ml of ALS. Mice were
housed 6 to a metal cage (groups of 14-24
mice) and kept in an isolation cabinet.
Sterile disposable syringes and needles were
used to administer sera, and were renewed
after injecting the mice housed in each cage.
Leprosy infection.-Mice, 8-9 weeks old,
were infected by inoculation of 105 M. teprae
(in sterile 0-1% bovine albumin-saline) into
both hind footpads. Bacilli were obtained
by homogenization of a leproma freshly
excised from an untreated patient.
Polyoma virus infection.-Mice were in-
fected by intraperitoneal injection of 105
TCD polyoma virus (Mill Hill strain) and were
housed in a separate building and not
inoculated with M. teprae.
Polyoma haemagglutination-inhibition (HI)
antibody test.-After treatment with receptor-
destroying enzyme (Wellcome), mouse sera
were titrated for polyoma HI antibodies
according to standard techniques (Rowe et al.,
1959; Hartley and Rowe, 1959). Stock mice
were found to be free of detectable polyoma
HI antibodies at the beginning of the
experiments.
Adoptive transfer of immunity against
polyoma tumours.-Adult CBA mice were
injected with polyoma virus and after 3 weeks
the spleens were excised. Spleen cell suspen-
sions were prepared (in sterile balanced salt
solution) and were injected either intraperi-
toneally or intravenously so that each iso-
geneic recipient received 2 x 107 cells.
Control mice were injected with normal
spleen cells.
Polyoma antibody.-Adult CBA mice of
both sexes were infected with polyoma virus
and 3 weeks later they were bled out and
serum taken. A pool of antibody with a HI
titre of 2460 and a neutralization titre of
greater than 100 was obtained. Each re-
cipient was inoculated intraperitoneally with
0-2 ml of this pool.
Autopsy of mice.-Moribund tumour-
bearing mice were killed by cervical disloca-
tion and full autopsies were performed.
Tissues (tumour, intestines, spleen, adrenal
gland, liver, kidney, lung, heart, salivary
glands andlymphnodes) werefixedin formol-
acetic-alcohol; bony tissues were decalcified
in versene. After embeddingin paraffin wax,
tissues were sectioned at 4 ,um and stained
with Ehrlich'shaematoxylin and eosin, carbol
fuchsin for acid-alcohol fast bacilli, or PAS
for fungi.
RESULTS
Incidental infection with polyoma virus in
immunosuppressed mice
Mice treated by thymectomy, either
alone or combined with ALS administra-
tion or 900 rad irradiation, were observed
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throughout their lifespan for the appear-
ance of tumours or other pathological
abnormality. Malignant tumours, and
occasionally non-malignant tumours, be-
gan to appear in thymectomized mice 4
months after commencement of ALG
treatment. The frequency and distribu-
tion of tumours amongst the various
groups of experimental mice are shown in
Table I (Group A). When tumours first
began to appear in these thymectomized-
ALG-treated mice, half the number of
remaining mice of this group which had
no detectable tumours (subsequently called
Group A1) received an intraperitoneal
injection of 2 0 x I10 viable splenic
mononuclear cells collected from adult
CBA mice that had previously been
veloped tumours, which first appeared 7-5
months after commencement of ALG
administration. The 2 remaining mice of
this group died with extensive non-
malignant granulomata, possiblycaused by
fungi sincefungal elements were sometimes
found in the mouse tissues. Animals in
this group developed tumours after a
longer interval than those observed in
thymectomized mice treated with ALG
(Group A). Somewhat surprisingly, only
one mouse in the thymectomized-900 rad
irradiated group (Group C) developed a
tumour, an osteosarcoma.
Tumours were of various histological
types, mostly rapidly growing adenocar-
cinomata, probably arising in breast;
osteosarcomata (in ribs, vertebrae, pelvic
TABLE. I-Tumours Appearing in Immunosuppressed Female CBA Mice
(Observedfor up to Two Years)
ALG
+
+
No. mice
with
tumours/
900 rad no. treated
- . 17/17
- . 0/14
- 22/24t
+ 1/18
- . 0/18
- . 0/16
* Group Al with adoptive immunity (see text for details).
t Two mice died with non-malignant granulomata.
All mice were infected with leprosy except those in group E.
immunized against polyoma virus (i.e.
adoptive immunization of the immuno-
suppressed mice). These mice received no
further treatment with ALG. Only in the
Group B mice (Table I) was ALG treat-
ment continued until the mice became
moribund. Over a period of 24 months
tumours developed in all 17 mice not
receiving spleen cells, whereas none of the
14 mice with adoptive immunity de-
veloped tumours (Table I). The distri-
bution, frequencv and classification of
tumours and other abnormalities are
listed in Table II.
Another group of 24 mice received
ALG alone without prior thvmectomy
(Group B); 22 of these eventually de-
girdle or tibia), and fibrosarcomata, pos-
sibly arising in the rib periosteum.
Unlike in our previous study (Gaugas et
al., 1969), salivary gland tumours- which
are the most common type of polyoma
tumour in most mouse strains infected
with most strains of the virus were
rarely found. As expected, bone tumours
grew much less rapidly than adenocarci-
nomata. No reticulo-endothelial tumours
were obtained but the lymph nodes of
mice that had received ALG showed the
features characteristic of such treatment,
namely involution of the paracortical
regions and replacement with macrophages
and filling of the medulla with plasma
cells. Tumours failed to appear in normal
Grouip
A
Al*
B
C
D (controls)
E
Thymectomy
at 6
weeks
±
+
Neonatal
thymectomy
Primed at
6 and 8
weeks
+
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TABLE II.-Time of Appearance, Site and Classification of Tumours and Other Lesions
in Immunosuppressed Female CBA Mice
Appearance after
starting ALG or
900 rad treatments
(months)
4-10
Site of tumour
or other
lesion
Subcutaneous
Pelvic girdle,
rib, vertebrae
or tibia
Uterus
Salivary gland
Xiphisternum,
skin
Stomach
Subcutaneous
Pelvic girdle,
vertebrae,
7 ribs
Salivary gland
Adrenal gland
Lymph node
Lungs
Liver
Bone
L
{.
Numbers and
classification
4 Undifferentiated
1 Breast adenocarcinoma
6 Poorly differentiated
adenocarcinomata
1 Undifferentiated spindle-cell
sarcoma
1 "Carcino-sarcoma " type
5 Osteosarcomata
1 Sarcoma
1 Sarcoma
2 Haemangiomata
2 Non-malignant ulcers
8 Undifferentiated
1 Breast adenocarcinoma
9 Poorly differentiated
adenocarcinomata
2 Spindle-cell sarcomata
1 Epithelial tumour
1 Fungal granuloma
7 Osteosarcomata
1 Peri-osteal sarcoma
1 Sarcoma
1 Polygon-cell carcinoma
1 Secondary carcinoma
1 Secondary carcinoma
1 Emboli of tumour cells in
vesselst
1 Paraportal collection of
pigment cells
1 Calcified small lesion
1 Osteosarcoma
* Groups D (controls) and E (neonatally thymectomized mice) showed no tumours.
t Fluid-filed ovarian cysts were seen in 2 Group B mice, but were not examined histologically.
I Mouse also had an undifferentiated subcutaneous tumour.
control mice, which were observed for 2
years. No tumours appeared in a group
of 16 neonatally thymectomized mice
observed until their deaths after 1-5-6
months.
Adenocarcinomata, which were solid
in immunosuppressed mice, were trans-
plantable under the skin of normal CBA
mice. In this situation they quickly
showed central necrosis and much infil-
tration by lymphocytes, macrophages and
some polymorphonuclear leucocytes. The
tumours then lost their original solid
appearance, but remained malignant,
infiltrating into muscle and retaining their
transplantability. This histological pic-
ture indicates that the tumour in the
normal mouse elicited a cell-mediated
reaction, with possibly a mild antibody-
mediated response superimposed.
A control group of mice injected twice
weekly, from the day ofbirth with 0 1-0 5
ml of normal rabbit serum until 6 weeks
old, failed to develop tumours in their
lifespan (12 mice). This result suggests
that polyoma virus was absent from the
rabbit serum used.
Recently, Nehlsen (1971) treated mice
throughout their lifespan with heterolo-
gous antithymocyte serum and obtained a
Group*
A
Bt 7J-15
C 5
1314 J. M. GAUGES, A. C. ALLISON, F. C. CHESTERMAN, R. J. W. REES AND M. S. HIRSCH
FiG. 1.-Mammary adenocarcinoma. x 230.
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FIG. 3. Osteosarcoma. x 230.
high incidence of amyloid in the mice
(Simpson and Nehlsen, 1971). Only a few
of our mice showed amyloid in the spleen
and kidney, which may have been due to
the fact that we used ALG rather than
ALS. The amyloid in Nehlsen's mice may
have been induced by the higher serum
protein content (in particular albumin) in
the ALS used.
All groups of mice had HI antibody
titres ranging from 320 to 12,800 when
tested towards the end of the experiment,
showing that they had been infected with
polyoma virus.
Deliberate infection of inmmunosuppressed
mice with polyoma virus
Virgin female mice of the CBA strain
were thymectomized at 6 weeks and given
weekly subcutaneous injections of 0 4 ml
rabbit antilymphocytic globulin (ALG).
Control mice were given normal rabbit
globulin (NRG). Ten days after the
2
inception ofALG or NRG treatment, mice
were given intraperitoneal injections of
105 TDC50 polyoma virus. ALG treat-
ment was continued for 7 weeks, at which
time the first tumour appeared. At the
eighth week the mice were divided into 3
groups: one was untreated, the second was
given spleen cells from normal adult CBA
mice (106 cells per g bodyweight of
recipient intravenously), and the third
was given the same number of spleen cells
from adult CBA mice infected 3 weeks
previously with polyoma virus. No
further ALG or NRG was given.
The results are shown in Table III.
Before infection, none of the mice had
a,ntibodies against polyoma virus. All sera
tested at 8 weeks in all groups showed
haemagglutination inhibiting antibodies
against polyoma virus. All ofthe thymec-
tomized and ALG-treated mice with no
restoration, and all but one of the mice
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TABLE III.-Developrnent of Turnours in Mice Infected with Polyomna Virus in the
Absence of Leprosy
Preliminary
treatment
NRG
Thymectomy
+ ALG
Thymectomy
+ ALG
Thymectomy
+ ALG
Restoration at,
7 weeks
None
None
Normal
lymphoid cells
Sensitized
lymphoidl cells
showed tumours. None of the mice
receiving sensitized lymphoid cells has
developed a tumour during 18 months of
further observation.
To examine further the effects of
restoration of cell-mediated immunity, 18
mice with small mammary tumours about
5 mm in diameter were taken and the
tumours excised under ether anaesthesia.
Half of the mice were given 5 X 106
polyoma-sensitized syngeneic spleen cells
intravenously, and the others left alone.
All the mice in the latter group developed
tumours due to recurrence or separate
origin; only 1 of the 9 mice receiving sen-
sitized lymphoid cells has developed a
tumour.
In a similar experiment, thymectomy
and ALG treatment was again found to
give rise to tumours in all 14 adult CBA
mice infected with polyoma virus. Ad-
ministration of 0-2 ml pQlyoma antibody
one day before virus infection prevented
the occurrence of tumours in 10 animals,
whereas administration of polyoma anti-
body at 7 and 8 weeks had no demon-
strable effect on the appearance of
tumours in 11 animals.
DISCUSSION
These findings confirm the observation
that thymectomy plus ALG treatment is a
more potent immunosuppressive regimen
for induction of polyoma tumours than
either procedure alone, and is much more
effective than thymectomy plus 900 rad
whole-body irradiation. Law (1966) and
Allison and Taylor (1967) found tumours
in only a minority of thymectomized mice
infected as adults with polyoma virus and
Nehlsen (1971) had similar results after
administration of ALS alone.
Viruses other than polyoma, for ex-
ample the mammary tumour agent or
FBJ virus (Finkel, Biskis and Jinkins,
1966), might conceivably have been acti-
vated by the immunosuppressive
treatments, although no evidence of
concurrent infection with other viruses
was found in this or in our previous studies
(Gaugas et al., 1969). Nevertheless, a few
mice succumbed to a fungal infection
which was not specifically identified. Thus
an enhancement in susceptibility to fungal
infection as well as virus oncogenesis were
operative. The prevention of tumours by
transfers of lymphoid cells from polyoma-
immune animals provides further evidence
that the spontaneously appearing tumours
in our mice infected with leprosy were in
fact induced by the virus.
Local persistence and proliferation of
M. leprae was probably insufficient to have
exerted any immunosuppressive effect
(Turk and Waters, 1968; Ptak et al.,
1970), since no macroscopical leprosy
lesions were obtained in the injected
footpads. Indeed, the relatively few
bacilli present may have had an adjuvant
effect on the production of immunity to
whatever degree it existed in the immuno-
suppressed mice throughout their lifespan.
However, the fact that similar results were
obtained in the absence of leprosy infec-
tion shows that the organisms were
unnecessary.
Taken together, observations from
both the incidental and deliberate polyoma
virus infection experiments demonstrate
that the main factor allowing virus
oncogenesis in the thymectomized-ALG-
No. of
animals
24
14
10
11
% with
tumours
0
100
90
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treated adult mouse is suppression of
cell-mediated immunity. The effect can
be reversed by restoration with lymphoid
cells from specifically sensitized syngeneic
donors, even when these were carried out
long after infection and, presumably,
oncogenic transformation of cells in the
recipients. The failure of restoration by
normal lymphoid cells is presumably a
result of timing and parallels previous
experience of restoration after neonatal
thymectomy (Allison, 1970): the normal
lymphoid cells prevent tumour formation
only when transferred one week after
virus inoculation, whereas sensitized cells
are effective when transferred one month
after virus inoculation. The prevention of
reappearanceofexcisedtumoursbytransfer
ofsensitizedlymphoidcellsshowsthatunder
optimal conditions immunotherapy can be
a remarkably effective adjunct to surgery.
The results presented in this paper
provide the strongest experimental evi-
dence yet available for the existence of an
immunological surveillance mechanism
against oncogenesis. Many mouse colonies
carry polyoma virus, which is potentially
oncogenic, and yet natural infections
hardly ever result in tumours. In such
colonies there is no vertical transmission of
virus. Newborn mice are passively pro-
tected by maternal antibody, and are
infected only when this passive protection
has waned. By this age their immune
responses against polyoma tumours are
early and effective (Allison, 1970). There
is, however, no limitation of the capacity
of the virus to multiply and produce an
oncogenic transformation in host cells, as
the results of infecting highly immuno-
suppressed animals show.
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